Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects

Abstract

These results suggest that short-term treatment with valproate at a dose of 625 mg/d does not alter hypothalamic or pituitary 5-HT1A or dopamine receptor responses to challenges with ipsapirone and apomorphine, respectively.